Focus on basic research, new technology development and application transformation of active bovine collagen.

FIMAN always adheres to strict quality standards, protecting safety and beauty through technology and craftsmanship.

Officially marking the grand opening of FIMAN’s in-depth layout of the full industrial chain of active collagen and the brand-new upgrade of intelligent manufacturing.

China’s first dedicated group standard for the evaluation of tissue-extracted injectable collagen in improving skin texture and complexion has been released, filling the industry gap.

At ICIC 2026, FIMAN won multiple top awards for its outstanding innovation, premium quality and cutting-edge technology.

Mr. Chen Xinwei, Managing Director of Fiman Biotech, stood out from numerous industry elites with his outstanding leadership, robust innovation capability and remarkable social contributions.

FIMAN Wins Prestigious "China Medical Aesthetics Industry Chain Award · Leading Enterprise in Medical Aesthetic Injectables and Materials"

With outstanding performance across five key areas, it stood out and won the title of "2026 Forbes China Industry Development Leading Enterprise".